Publications for Macdonald Christie 2016

Publications for Macdonald Christie

2016

Leah, P., Heath, E., Balleine, B., Christie, M.

(2016). Chronic Morphine Reduces Surface

Expression of δ-Opioid Receptors in Subregions of Rostral Striatum. Neurochemical Research ,

41(3), 500-509. <a href="http://dx.doi.org/10.1007/s11064-015-163

8-6">[More Information]</a>

Wan, J., Brust, A., Bhola, R., Jha, P., Mobli, M.,

Lewis, R., Christie, M., Alewood, P. (2016).

Inhibition of the norepinephrine transporter by

χ-conotoxin dendrimers. Journal of Peptide

Science , 22(5), 280-289. <a href="http://dx.doi.org/10.1002/psc.2857">[Mor e Information]</a>

2015

Imlach, W., Bhola, R., May, L., Christopoulos,

A., Christie, M. (2015). A Positive Allosteric

Modulator of the Adenosine A1 Receptor

Selectively Inhibits Primary Afferent Synaptic

Transmission in a Neuropathic Pain Model.

Molecular Pharmacology , 88(3), 460-468. <a href="http://dx.doi.org/10.1124/mol.115.099499

">[More Information]</a>

Connor, M., Bagley, E., Chieng, B., Christie, M.

(2015). beta-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single

PAG neurons. British Journal of Pharmacology ,

172(2), 492-500. <a href="http://dx.doi.org/10.1111/bph.12673">[Mo re Information]</a>

Cox, B., Christie, M., Devi, L., Toll, L., Traynor,

J. (2015). Challenges for Opioid Receptor

Nomenclature: IUPHAR Review 9. British

Journal of Pharmacology , 172(2), 317-323. <a href="http://dx.doi.org/10.1111/bph.12612">[Mo re Information]</a>

Mohammadi, S., Christie, M. (2015). Conotoxin

Interactions with α9α10-nAChRs: Is the α9α10

Nicotinic Acetylcholine Receptor an Important

Therapeutic Target for Pain Management?

Toxins , 7(10), 3916-1932. <a href="http://dx.doi.org/10.3390/toxins7103916">

[More Information]</a>

Munasinghe, N., Christie, M. (2015). Conotoxins

That Could Provide Analgesia through Voltage

Gated Sodium Channel Inhibition. Toxins , 7(12),

5386-5407. <a href="http://dx.doi.org/10.3390/toxins7124890">


Murali, S., Napier, I., Mohammadi, S., Alewood,

P., Lewis, R., Christie, M. (2015).

High-voltage-activated calcium current subtypes

Publications for Macdonald Christie in mouse DRG neurons adapt in a subpopulation-specific manner after nerve injury.

Journal of Neurophysiology , 113(5), 1511-1519.

<a href="http://dx.doi.org/10.1152/jn.00608.2014">


Christie, M. (2015). Opioids and their signalling mechanisms at opioid receptors. In Patricia

Armati, Roberta Chow (Eds.), Pain: The person, the science, the clinical interface , (pp. 205-220).

Melbourne: IP Communications.

Shan, Q., Christie, M., Balleine, B. (2015).

Plasticity in striatopallidal projection neurons mediates the acquisition of habitual actions. European Journal of Neuroscience , 42(4), 2097-2104. <a href="http://dx.doi.org/10.1111/ejn.12971">[Mo re Information]</a>

Gori, A., Wang, C., Harvey, P., Rosengren, K.,

Bhola, R., Gelmi, M., Longhi, R., Christie, M.,

Lewis, R., Alewood, P., et al (2015).

Stabilization of the Cysteine-Rich Conotoxin

MrIA by Using a 1,2,3-Triazole as a Disulfide

Bond Mimetic. Angewandte Chemie

(International Edition) , 54(4), 1361-1364. <a href="http://dx.doi.org/10.1002/anie.201409678"

>[More Information]</a>

Yousuf, A., Miess, E., SIANATI, S., Du, Y.,

Schulz, S., Christie, M. (2015). The Role of

Phosphorylation Sites in Desensitization of u-Opioid Receptor. Molecular Pharmacology ,

88(4), 825-835. <a href="http://dx.doi.org/10.1124/mol.115.098244


Christie, M., Connor, M., Traynor, J. (2015).

Themed section. British Journal of

Pharmacology , 172(2), 247-250. <a href="http://dx.doi.org/10.1111/bph.13028">[Mo re Information]</a>

Sadeghi, M., Tzschentke, T., Christie, M. (2015).

μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons. British Journal of

Pharmacology , 172(2), 460-468. <a href="http://dx.doi.org/10.1111/bph.12566">[Mo re Information]</a>

2014

Mohammadi, S., Christie, M. (2014).

Alpha9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia. Molecular Pain , 10(1),

1-9. <a href="http://dx.doi.org/10.1186/1744-8069-10-6

4">[More Information]</a>

Vandenberg, R., Ryan, R., Carland, J., Imlach,

Publications for Macdonald Christie

W., Christie, M. (2014). Glycine transport inhibitors for the treatment of pain. Trends In

Pharmacological Sciences , 35(8), 423-430. <a href="http://dx.doi.org/10.1016/j.tips.2014.05.00


Jin, A., Vetter, I., Dutertre, S., Abraham, N.,

Emidio, N., Inserra, M., Murali, S., Christie, M.,

Alewood, P., Lewis, R. (2014). MrIC, a novel

α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors.

Biochemistry , 53(1), 1-3. <a href="http://dx.doi.org/10.1021/bi400882s">[Mo re Information]</a>

Shan, Q., Ge, M., Christie, M., Balleine, B.

(2014). The acquisition of goal-directed actions generates opposing plasticity in direct and indirect pathways in dorsomedial striatum. The

Journal of Neuroscience , 34(28), 9196-9201. <a href="http://dx.doi.org/10.1523/JNEUROSCI.03

13-14.2014">[More Information]</a>

Imlach, W., Christie, M. (2014). The light touch of delta opioid receptors. Neuron , 81(6),

1220-1222. <a href="http://dx.doi.org/10.1016/j.neuron.2014.03

.004">[More Information]</a>

2013

Knapman, A., Santiago, M., Du, Y., Bennallack,

P., Christie, M., Connor, M. (2013). A

Continuous, Fluorescence-based Assay of u-Opioid Receptor Activation in AtT-20 Cells.

Journal of Biomolecular Screening , 18(3),

269-276. <a href="http://dx.doi.org/10.1177/1087057112461


Saberi, S., Du, Y., Christie, M., Goldsbury, C.

(2013). Human Chorionic Gonadotropin

Increases b-Cleavage of Amyloid Precursor

Protein in SH-SY5Y Cells. Cellular and

Molecular Neurobiology , 33(6), 747-751. <a href="http://dx.doi.org/10.1007/s10571-013-995

4-3">[More Information]</a>

Bertran-Gonzalez, J., Laurent, V., Chieng, B.,

Christie, M., Balleine, B. (2013).

Learning-related translocation of δ-Opioid receptors on ventral striatal cholinergic interneurons mediates choice between goal-directed actions. The Journal of

Neuroscience , 33(41), 16060-16071. <a href="http://dx.doi.org/10.1523/JNEUROSCI.19


Sadeghi, M., Murali, S., Lewis, R., Alewood, P.,

Mohammadi, S., Christie, M. (2013). Novel

[omega]-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration. Molecular Pain , 9(1), 1-9. <a href="http://dx.doi.org/10.1186/1744-8069-9-51"


Williams, J., Ingram, S., Henderson, G.,

Chavkin, C., von Zastrow, M., Schulz, S., Koch,

T., Evans, C., Christie, M. (2013). Regulation of

& mu; -Opioid Receptors: Desensitization,

Phosphorylation, Internalization, and Tolerance.

Pharmacological Reviews , 65(1), 223-254. <a href="http://dx.doi.org/10.1124/pr.112.005942">


Jayamanne, A., Jeong, H., Schroeder, C., Lewis,

R., Christie, M., Vaughan, C. (2013). Spinal actions of omega-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

British Journal of Pharmacology , 170(2),

245-254. <a href="http://dx.doi.org/10.1111/bph.12251">[Mo re Information]</a>

Brust, A., Wang, C., Daly, N., Kennerly, J.,

Sadeghi, M., Christie, M., Lewis, R., Mobli, M.,

Alewood, P. (2013). Vicinal Disulfide

Constrained Cyclic Peptidomimetics: a Turn

Mimetic Scaffold Targeting the Norepinephrine

Transporter. Angewandte Chemie (International

Edition) , 52(46), 12020-12023. <a href="http://dx.doi.org/10.1002/anie.201304660"


2012

Vetter, I., Mozar, C., Durek, T., Wingerd, J.,

Alewood, P., Christie, M., Lewis, R. (2012).

Characterisation of Nav types endogenously expressed in human SH-SY5Y neuroblastoma cells. Biochemical Pharmacology , 83(11),

1562-1571. <a href="http://dx.doi.org/10.1016/j.bcp.2012.02.02


Lewis, R., Dutertre, S., Vetter, I., Christie, M.

(2012). Conus venom peptide pharmacology.

Pharmacological Reviews , 64(2), 259-298. <a href="http://dx.doi.org/10.1124/pr.111.005322">


Napier, I., Mohammadi, S., Christie, M. (2012).

Glutamate transporter dysfunction associated with nerve injury-induced pain in mice. Journal of Neurophysiology , 107(2), 649-657. <a href="http://dx.doi.org/10.1152/jn.00763.2011">


Napier, I., Klimis, H., Rycroft, B., Jin, A.,

Alewood, P., Motin, L., Adams, D., Christie, M.

(2012). Intrathecal a-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain.

Neuropharmacology , 62(7), 2202-2207. <a href="http://dx.doi.org/10.1016/j.neuropharm.20

12.01.016">[More Information]</a>

Dang, V., Christie, M. (2012). Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.



1704-1716. <a href="http://dx.doi.org/10.1111/j.1476-5381.201

1.01482.x">[More Information]</a>

Graeber, M., Christie, M. (2012). Multiple mechanisms of microglia: a gatekeeper's contribution to pain states. Experimental

Neurology , 234(2), 255-261. <a href="http://dx.doi.org/10.1016/j.expneurol.2012

.01.007">[More Information]</a>

Enoksson, T., Bertran-Gonzalez, J., Christie, M.

(2012). Nucleus accumbens D2- and D1-receptor expressing medium spiny neurons are selectively activated by morphine withdrawal and acute morphine, respectively. Neuropharmacology ,

62(8), 2463-2471. <a href="http://dx.doi.org/10.1016/j.neuropharm.20


Murali, S., Napier, I., Rycroft, B., Christie, M.

(2012). Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels. The

Journal of Physiology , 590(7), 1655-1667. <a href="http://dx.doi.org/10.1113/jphysiol.2012.22


Dang, V., Chieng, B., Christie, M. (2012).

Prolonged stimulation of u-opioid receptors produces B-arrestin-2-mediated heterologous desensitization of a2-adrenoceptor function in locus ceruleus neurons. Molecular

Pharmacology , 82(3), 473-480. <a href="http://dx.doi.org/10.1124/mol.112.079350


2011

Klimis, H., Adams, D., Callaghan, B., Nevin, S.,

Alewood, P., Vaughan, C., Mozar, C., Christie,

M. (2011). A Novel Mechanism of Inhibition of

High-Voltage Activated Calcium Channels by alpha-Conotoxins Contributes to Relief of Nerve

Injury-Induced Neuropathic Pain. Pain , 152(2),

259-266. <a href="http://dx.doi.org/10.1016/j.pain.2010.09.0


Morgan, M., Christie, M. (2011). Analysis of

Opioid Efficacy, Tolerance, Addiction, and

Dependence from Cell Culture to Human. British

Journal of Pharmacology , 164(4), 1322-1334. <a href="http://dx.doi.org/10.1111/j.1476-5381.201


Dang, V., Chieng, B., Azriel, Y., Christie, M.

(2011). Cellular Morphine Tolerance Produced by betaArrestin-2-Dependent Impairment of mu-Opioid Receptor Resensitization. The



Chieng, B., Azriel, Y., Mohammadi, S., Christie,

M. (2011). Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. The Journal of Physiology , 589(15), 3775-3787. <a href="http://dx.doi.org/10.1113/jphysiol.2011.21


Bagley, E., Hacker, J., Chefer, V., Mallet, C.,

McNally, G., Chieng, B., Perroud, J.,

Shippenberg, T., Christie, M. (2011).

Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nature Neuroscience ,

14(12), 1548-1554. <a href="http://dx.doi.org/10.1038/nn.2940">[More

Information]</a>

Kawahara, H., Drew, G., Christie, M., Vaughan,

C. (2011). Inhibition of fatty acid amide hydrolase unmasks

CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.


1214-1222. <a href="http://dx.doi.org/10.1111/j.1476-5381.201


Pedersen, N., Vaughan, C., Christie, M. (2011).

Opioid receptor modulation of GABAergic and serotonergic spinally-projecting neurons of the rostral ventromedial medulla in mice. Journal of

Neurophysiology , 106(2), 731-740. <a href="http://dx.doi.org/10.1152/jn.01062.2010">


Christie, M., Vaughan, C. (2011). Receptors:

Cannabis medicine without a high. Nature

Chemical Biology . <a href="http://www.ncbi.nlm.nih.gov/entrez/query.

fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract

&list_uids=21502945">[More Information]</a> de Araujo, A., Callaghan, B., Nevin, S., Daly, N.,

Craik, D., Moretta, M., Hopping, G., Christie,

M., Alewood, P., Adams, D. (2011). Total

Synthesis of the Analgesic Conotoxin MrVIB through Selenocysteine-assisted Folding.

Angewandte Chemie (International Edition) ,

50(29), 6527-6529. <a href="http://dx.doi.org/10.1002/anie.201101642"


2010

Berecki, G., Motin, L., Haythornthwaite, A.,

Vink, S., Bansal, P., Drinkwater, R., Wang, C.,

Moretta, M., Lewis, R., Alewood, P., Christie,

M., et al (2010). Analgesic omega-Conotoxins

CVIE and CVIF Selectively and

Voltage-Dependently Block Recombinant and

Native N-Type Calcium Channels. Molecular

Pharmacology , 77(2), 139-148. <a

href="http://dx.doi.org/10.1124/mol.109.058834


Morales, R., Daly, N., Vetter, I., Mobli, M.,

Napier, I., Craik, D., Lewis, R., Christie, M.,

King, G., Alewood, P., et al (2010). Chemical

Synthesis and Structure of the Prokineticin Bv8.

ChemBioChem: a European journal of chemical biology , 11(13), 1882-1888. <a href="http://dx.doi.org/10.1002/cbic.201000330"


Ittner, L., Ke, Y., Delerue, F., Bi, M., Gladbach,

A., Van Eersel, J., Wolfing, H., Chieng, B.,

Christie, M., Napier, I., Goetz, J., et al (2010).

Dendritic Function of Tau Mediates

Amyloid-beta Toxicity in Alzheimer's Disease

Mouse Models. Cell , 142(3), 387-397. <a href="http://dx.doi.org/10.1016/j.cell.2010.06.03


Chieng, B., Christie, M. (2010). Somatostatin and nociceptin inhibit neurons in the central nucleus of amygdala that project to the periaqueductal grey. Neuropharmacology , 59(6),

425-430. <a href="http://dx.doi.org/10.1016/j.neuropharm.20


2009

Morgan, M., Ashley, M., Ingram, S., Christie, M.

(2009). Behavioral Consequences of

Delta-Opioid Receptor Activation in the

Periaqueductal Gray of Morphine Tolerant Rats.

Neural Plasticity , 2009 (516328), 1-7. <a href="http://dx.doi.org/10.1155/2009/516328">[

More Information]</a>

Chieng, B., Christie, M. (2009). Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey.

Neuropharmacology , 57(4), 430-437. <a href="http://dx.doi.org/10.1016/j.neuropharm.20


Christie, M., Mallet, C. (2009).

Endocannabinoids can open the pain gate.

Science Signaling , 2(88), 57. <a href="http://dx.doi.org/10.1126/scisignal.288pe5


Dang, V., Napier, I., Christie, M. (2009). Two distinct mechanisms mediate acute mu-opioid receptor desensitization in native neurons. The



2008

Christie, M. (2008). Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. British

Journal of Pharmacology , 154(2), 384-396. <a

Publications for Macdonald Christie href="http://dx.doi.org/10.1038/bjp.2008.100">[

More Information]</a>

Chieng, B., Lee, D., Du, Y., Osborne, P.,

Christie, M., Massottec, D. (2008). Functional coupling of mu-receptor-Galphai-tethered proteins in AtT20 cells. NeuroReport , 19(18),

1793-1796. <a href="http://dx.doi.org/10.1097/WNR.0b013e32

83196b55">[More Information]</a>

2007

Nevin, S., Clark, R., Klimis, H., Christie, M.,

Craik, D., Adams, D. (2007). Are alpha 9 alpha

10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Molecular Pharmacology ,

72(6), 1406-1410.

Nevin, S., Clark, R., Klimis, H., Christie, M.,

Craik, D., Adams, D. (2007). Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Molecular Pharmacology ,

72(6), 1406-1410. <a href="http://dx.doi.org/10.1124/mol.107.040568


Rycroft, B., Vikman, K., Christie, M. (2007).

Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina

I neurons in the rat dorsal horn. The Journal of

Physiology , 580(3), 883-894. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.


&list_uids=17303639">[More Information]</a>

Christie, M., Osborne, P. (2007). Opioid

Electrophysiology in PAG. In Robert F.

Schmidt, William D. Willis (Eds.), Encyclopedia of Pain . (pp. 1532-1534). Germany: Springer.

Vikman, K., Rycroft, B., Christie, M. (2007).

Switch to Ca2+ permeable AMPA and reduced

NR2B NMDA receptor mediated neurotransmission at dorsal horn nociceptive synapses during inflammatory pain in the rat.

The Journal of Physiology , 586(2), 515-527. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.



Liu, X., Banister, S., Christie, M., Banati, R.,

Meikle, S., Coster, M., Kassiou, M. (2007).

Trishomocubanes: Novel sigma ligands modulate cocaine-induced behavioural effects.

European Journal of Pharmacology , 555(1),

37-42.

2006

Jennings, E., Christie, M., Sessle, B. (2006).

ATP potentiates neurotransmission in the rat trigeminal subnucleus caudalis. NeuroReport ,

17(14), 1507-1510. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.

Publications for Macdonald Christie fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract


Chieng, B., Christie, M., Osborne, P. (2006).

Characterization of neurons in the rat central nucleus of the amygdala: Cellular physiology, morphology, and opioid sensitivity. The Journal of Comparative Neurology , 497(6), 910-927. <a href="http://dx.doi.org/10.1002/cne.21025">[Mo re Information]</a>

Hacker, J., Pedersen, N., Chieng, B., Keay, K.,

Christie, M. (2006). Enhanced Fos expression in glutamic acid decarboxylase immunoreactive neurons of the mouse periaqueductal grey during opioid withdrawal. Neuroscience , 137(4),

1389-1396. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.



Christie, M., Bagley, E., Hacker, J., Chieng, B.

(2006). GABA transporters in drug dependence:

Neuronal or glial. International Society for

Biomedical Research on Alcoholism World congress on Alcohol Research (ISBRA 2006) ,

Maryland: Wiley-Blackwell Publishing.

Zwar, N., Bell, J., Peters, M., Christie, M.,

Mendelsohn, C. (2006). Nicotine and nicotine replacement therapy - the facts. Australian

Pharmacist , 25(2), 969-973.

Christie, M. (2006). Opioid and cannabinoid receptors: Friends with benefits or just close friends? British Journal of

Pharmacology , 148(4), 385-386. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.



Riddell, S., Nielssen, O., Butler, T., Christie, M.,

Starmer, G. (2006). The Relationship Between

Amphetamine Use, Crime and Psychiatric

Disorder Among Prisoners in New South Wales.

Psychiatry Psychology and Law , 13(2), 160-165.

Liu, X., Banister, S., Christie, M., Banati, R.,

Meikle, S., Coster, M., Kassiou, M. (2006).

Trishomocubanes: Novel Sigma ligands modulate cocaine-induced behavioural effects.

European Journal of Pharmacology , 555(1),




Ekberg, J., Jayamanne, A., Vaughan, C., Aslan,

S., Thomas, L., Mould, J., Drinkwater, R., Baker,

M., Abrahamsen, B., Wood, J., Christie, M., et al

(2006). microO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proceedings of the National

Academy of Sciences of the United States of

America (PNAS) , 103(45), 17030-17035. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.



2005

Hall, W., Christie, M., Currow, D. (2005).

Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncology ,




Marinelli, S., Connor, M., Schnell, S., Christie,

M., Wessendorf, M., Vaughan, C. (2005). delta-OPIOID RECEPTOR-MEDIATED

ACTIONS ON ROSTRAL VENTROMEDIAL

MEDULLA NEURONS. Neuroscience , 132(2),




Chieng, B., Hallberg, C., Nyberg, F., Christie, M.

(2005). Enhanced c-Fos in periaqueductal grey

GABAergic neurons during opioid withdrawal.

NeuroReport , 16(12), 1279-1283. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.



Bagley, E., Gerke, M., Vaughan, C., Hack, S.,

Christie, M. (2005). GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron ,




Hack, S., Bagley, E., Chieng, B., Christie, M.

(2005). Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. The Journal of Neuroscience , 25(12),




Liu, X., Mattner, F., Katsifis, A., Christie, M.,

Kassiou, M. (2005). Influence of

Trishomocubanes on Sigma Receptor Binding of

N-(1-Benzylpiperidin-

4-yl)-4-[123I]iodobenzamide In Vivo in the Rat

Brain. Medicinal Chemistry , 1(1), 31-38. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.



Vaughan, C., Christie, M. (2005). Mechanisms of cannabinoid analgesia. Cannabis and

Cannabinoids: Pharmacology, Toxicology and

Therapeutic Potential , (pp. 89-100). UK:


Harworth Press.

Bagley, E., Chieng, B., Christie, M., Connor, M.

(2005). Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. British Journal of

Pharmacology , 146(1), 68-76. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.



Hauser, K., Aldrich, J., Anderson, K., Bakalkin,

G., Christie, M., Hall, E., Knapp, P., Scheff, S.,

Singh, I., Vissel, B., et al (2005). Pathobiology of dynorphins in trauma and disease. Frontiers in

Bioscience , 10(1), 216-235.

Vaughan, C., Christie, M. (2005). Retrograde signalling by endocannabinoids. In Pertwee R

(Eds.), Handbook of Experimental

Pharmacology , (pp. 367-384). Heidelberg:

Springer.

Johnson, E., Christie, M., Connor, M. (2005).

The Role of Opioid Receptor Phosphorylation and Trafficking in Adaptations to Persistent

Opioid Treatment. NeuroSignals , 14(6), 290-302.

<a href="http://www.ncbi.nlm.nih.gov/entrez/query.



2004

Connor, M., Bagley, E., Mitchell, V., Ingram, S.,

Christie, M., Humphrey, P., Vaughan, C. (2004).

Cellular Actions Of Somatostatin On Rat

Periaqueductal Grey Neurons In Vitro. British

Journal of Pharmacology , 142(8), 1273-1280.

Dean, A., Bell, J., Christie, M., Mattick, R.

(2004). Depressive Symptoms During

Buprenorphine Vs. Methadone Maintenance:

Findings From A Randomised, Controlled Trial

In Opioid Dependence. European Psychiatry ,

19(8), 510-513. <a href="http://dx.doi.org/10.1016/j.eurpsy.2004.09.


Jennings, E., Ryan, R., Christie, M. (2004).

Effects Of Sumatriptan On Rat Medullary Dorsal

Horn Neurons. Pain , 111(1-2), 30-37.

Christie, M., Vaughan, C. (2004). Mechanismen

Der Cannabinoidanalgesie. In Franjo

Grotenhermen (Eds.), Cannabis und

Cannabinoide , (pp. 115-125). Bern: Nicholson

Museum, University of Sydney.

Connor, M., Osborne, P., Christie, M. (2004).

Mu-Opioid Receptor Desentization: Is Morphine

Different? British Journal of Pharmacology ,

143(6), 685-696.

Marinelli, S., Schnell, S., Hack, S., Christie, M.,

Wessendorf, M., Vaughan, C. (2004).

Serotonergic And Nonserotonergic Dorsal Raphe

Neurons Are Pharmacologically And

Electrophysiologically Heterogeneous. Journal of Neurophysiology , 92(6), 3532-3537.

2003

Hack, S., Christie, M. (2003). Adaptations in adenosine signaling in drug dependence: therapeutic implications. Critical Reviews in

Neurobiology , 15(3-4), 235-274.

Vaughan, C., Bagley, E., Drew, G., Schuller, A.,

Pintar, J., Hack, S., Christie, M. (2003). Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. British Journal of

Pharmacology , 139(2), 362-367.

Mitchell, V., Christie, M., Vaughan, C. (2003).

Developmental changes in the alpha-adrenergic responses of rat periaqueductal grey neurons.

NeuroReport , 14(12), 1637-1639.

Hack, S., Vaughan, C., Christie, M. (2003).

Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.

Neuropharmacology , 45(5), 575-584.

Lonergan, T., Goodchild, A., Christie, M.,

Pilowsky, P. (2003). Mu opioid receptors in rat ventral medulla: effects of endomorphin-1 on phrenic nerve activity. Respiratory Physiology and Neurobiology , 138(2-3), 165-178.

Borgland, S., Connor, M., Osborne, P., Furness,

J., Christie, M. (2003). Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization and endocytosis of Mu-opioid receptors. Journal of Biological

Chemistry , 278(21), 18776-18784. <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?

cmd=Retrieve&db=pubmed&list_uids=1264257


Lonergan, T., Goodchild, A., Christie, M.,

Pilowsky, P. (2003). Presynaptic delta opioid receptors differentially modulate rhythm and pattern generation in the ventral respiratory group of the rat. Neuroscience , 121(4), 959-973.

Jennings, E., Vaughan, C., Roberts, L., Christie,

M. (2003). The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. The Journal of Physiology , 548(1),

121-129.

King, W., Borland, R., Christie, M. (2003).

Way-out developments at BATCO. Tobacco

Control , 12(1), 107-108.

2002

Dean, A., Bell, J., Mascord, D., Parker, G.,

Christie, M. (2002). A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptoms. Journal of

Affective Disorders , 72(1), 85-90.

Roberts, L., Christie, M., Connor, M. (2002).

Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. British Journal of

Pharmacology , 137(4), 421-428.

Marinelli, S., Vaughan, C., Christie, M., Connor,

M. (2002). Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. The Journal of Physiology , 543(2),

531-540.

Osborne, P., Vidovic, M., Chieng, B., Hill, C.,

Christie, M. (2002). Expression of mRNA and functional alpha1-adrenoceptors that supress the

GIRK conductance in adult rat locus coeruleus neurons. British Journal of Pharmacology , 13(1),

226-232.

Dedov, V., Tran, V., Duke, C., Connor, M.,

Christie, M., Mandadi, S., Roufogalis, B. (2002).

Gingerols: a novel class of vanilloid receptor

(VR1) agonists. British Journal of

Pharmacology , 137(6), 793-798.

Vaughan, C., Christie, M. (2002). Mechanisms of Cannabinoid Analgesia. In Grotenhermen, F

& Russo, E (Eds.), Cannibis and Cannabinoids:

Pharmacology, Toxicology, and Therapeutic

Potential , (pp. 89-99). Binghampton, NY, USA:

Staempfli Publishers Ltd.

Borgland, S., Connor, M., Ryan, R., Ball, H.,

Christie, M. (2002). Prostaglandin E2 inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. The Journal of Physiology , 539(2),

433-444.

Marinelli, S., Vaughan, C., Schnell, S.,

Wessendorf, M., Christie, M. (2002). Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. The Journal of Neuroscience ,

22(24), 10847-10855.

2001

Vaughan, C., Connor, M., Jennings, E.,

Marinelli, S., Christie, M., Allen, R. (2001).

Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. The

Journal of Physiology , 534, 849-859.

Jennings, E., Vaughan, C., Christie, M. (2001).

Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro. The Journal of

Physiology , 534, 805-812.

Christie, M., Williams, J., Manzoni, O. (2001).

Cellular and synaptic adaptations mediating opioid dependence. Physiological Reviews , 81,

299-343.

Wang, X., Connor, M., Wilson, D., Wilson, H.,

Nicholson,, G., Smith, R., Shaw, D., Mackay, J.,


Alewood, P., Christie, M., et al (2001).

Discovery and structure of a potent and highly specific blocker of insect calcium channels.

Journal of Biological Chemistry , 276,

40306-40312.

Vaughan, C., Christie, M. (2001). Mechanisms of cannabinoid analgesia. In Franjo

Grotenhermen (Hrsg) (Eds.), Cannabis and

Cannabinoide , (pp. 109-119). Germany:

Academic Press.

Borgland, S., Connor, M., Christie, M. (2001).

Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganlion neurons in mouse. The Journal of

Physiology , 536, 35-47.

Liu, X., Christie, M., Kassiou, M., Nuwayhid, S.,

Werling, L. (2001). Trishomocubanes: Novel sigma-ligands modulate amphetamine-stimulated

[3H]dopamine release. European Journal of

Pharmacology , 422, 39-45.

Liu, X., Kassiou, M., Christie, M., Hambley, T.

(2001). Trishomocubanes: requirements for sigma receptor binding and subtype selectivity.

Australian Journal of Chemistry , 54, 31-36.

Publications for Macdonald Christie 2016

Related documents

Products

Support

Publications for Macdonald Christie 2016

Related documents

Add this document to collection(s)

Add this document to saved

Suggest us how to improve StudyLib